Mereo BioPharma Group reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Mereo BioPharma Group using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $-0.01 | $-0.01 | 0.00 % |
| Q2 | 2025-08-12 | $-0.02 | $-0.01 | -100.0 % |
| Q1 | 2025-05-13 | $-0.02 | $-0.01 | -100.0 % |
| Q4 | 2025-03-26 | $-0.01 | $-0.01 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-10 | $0 | $16.22M | -100.0 % |
| Q1 | 2025-05-13 | $0 | $11.89M | -100.0 % |
Mereo BioPharma Group (MREO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3.
Mereo BioPharma Group (MREO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3 and the Actual EPS was $-0.01, which hit the estimate of $-0.01.
Mereo BioPharma Group (MREO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 10, 2025 for Q3 and the Actual Revenue was $0K, which missed the estimate of $16.2M.
Browse earnings estimates, EPS, and revenue on all stocks.